Literature DB >> 4960884

Trachoma vaccine studies in monkeys.

S P Wang, J T Grayston, E R Alexander.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1967        PMID: 4960884     DOI: 10.1016/0002-9394(67)94155-4

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


× No keyword cloud information.
  55 in total

1.  Protective immunity against mouse upper genital tract pathology correlates with high IFNγ but low IL-17 T cell and anti-secretion protein antibody responses induced by replicating chlamydial organisms in the airway.

Authors:  Chunxue Lu; Hao Zeng; Zhihong Li; Lei Lei; I-Tien Yeh; Yimou Wu; Guangming Zhong
Journal:  Vaccine       Date:  2011-11-10       Impact factor: 3.641

2.  The recall response induced by genital challenge with Chlamydia muridarum protects the oviduct from pathology but not from reinfection.

Authors:  Melissa M Riley; Matthew A Zurenski; Lauren C Frazer; Catherine M O'Connell; Charles W Andrews; Margaret Mintus; Toni Darville
Journal:  Infect Immun       Date:  2012-03-19       Impact factor: 3.441

3.  Vaccination with major outer membrane protein proteosomes elicits protection in mice against a Chlamydia respiratory challenge.

Authors:  Delia F Tifrea; Sukumar Pal; Deana N Toussi; Paola Massari; Luis M de la Maza
Journal:  Microbes Infect       Date:  2013-08-30       Impact factor: 2.700

4.  Expression of MHC class II antigens by conjunctival epithelial cells in trachoma: implications concerning the pathogenesis of blinding disease.

Authors:  D C Mabey; R L Bailey; D Dunn; D Jones; J H Williams; H C Whittle; M E Ward
Journal:  J Clin Pathol       Date:  1991-04       Impact factor: 3.411

5.  Enhancement of the protective efficacy of a Chlamydia trachomatis recombinant vaccine by combining systemic and mucosal routes for immunization.

Authors:  Pooja Ralli-Jain; Delia Tifrea; Chunmei Cheng; Sukumar Pal; Luis M de la Maza
Journal:  Vaccine       Date:  2010-09-25       Impact factor: 3.641

6.  Characterization of a neutralizing monoclonal antibody directed at variable domain I of the major outer membrane protein of Chlamydia trachomatis C-complex serovars.

Authors:  Z Qu; X Cheng; L M de la Maza; E M Peterson
Journal:  Infect Immun       Date:  1993-04       Impact factor: 3.441

7.  Genetic profiling of dendritic cells exposed to live- or ultraviolet-irradiated Chlamydia muridarum reveals marked differences in CXC chemokine profiles.

Authors:  Michelle L Zaharik; Tarun Nayar; Rick White; Caixia Ma; Bruce A Vallance; Nadine Straka; Xiaozhou Jiang; Jose Rey-Ladino; Caixia Shen; Robert C Brunham
Journal:  Immunology       Date:  2006-10-31       Impact factor: 7.397

8.  Gene knockout mice establish a primary protective role for major histocompatibility complex class II-restricted responses in Chlamydia trachomatis genital tract infection.

Authors:  R P Morrison; K Feilzer; D B Tumas
Journal:  Infect Immun       Date:  1995-12       Impact factor: 3.441

9.  Tear and serum antibody response to Chlamydia trachomatis antigens during acute chlamydial conjunctivitis in monkeys as determined by immunoblotting.

Authors:  H D Caldwell; S Stewart; S Johnson; H Taylor
Journal:  Infect Immun       Date:  1987-01       Impact factor: 3.441

10.  The influence of local antichlamydial antibody on the acquisition and persistence of human ocular chlamydial infection: IgG antibodies are not protective.

Authors:  R L Bailey; M Kajbaf; H C Whittle; M E Ward; D C Mabey
Journal:  Epidemiol Infect       Date:  1993-10       Impact factor: 2.451

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.